Author:
Sammon Jesse D.,McKay Rana R.,Kim Simon P.,Sood Akshay,Sukumar Shyam,Hayn Matthew H.,Hu Jim C.,Kibel Adam S.,Nguyen Paul L.,Peabody James O.,Saad Fred,Sun Maxine,Varda Briony,Menon Mani,Choueiri Toni K.,Trinh Quoc-Dien
Reference30 articles.
1. Howlader N Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute. Bethesda, MD.
2. Chemotherapy-based treatment for castration-resistant prostate cancer;Seruga;J Clin Oncol,2011
3. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012
4. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011
5. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer;Catalona;N Engl J Med,1991
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献